Email parthibane@nus.edu.sg

Parthibane’s work focuses on generating policy-relevant evidence to support better decision-making in health systems. Trained in epidemiology, health technology assessment (HTA), and public health, he conducts economic evaluations, systematic reviews, and population-based studies to inform priority setting and resource allocation for non-communicable disease (NCD) prevention and control.

Prior to joining NUS, he worked at the Health Technology Assessment Regional Resource Hub at JIPMER, India, where he contributed to HTA studies developed for government and policy use. His research spans cost-effectiveness analysis, the epidemiology of NCDs, and tobacco control.

His current research includes modelling the impact of obesity preventive health measures on population health outcomes in Singapore, the application of artificial intelligence and large language models to evidence synthesis and adaptive HTA, and capacity building in HTA.

• NUS Saw Swee Hock School of Public Health

• Health economics
• Health technology assessment
• Generative AI in health technology assessment
• Epidemiology of chronic conditions

• Ph.D. in Public Health, Jawaharlal Institute of Postgraduate Medical Education & Research (JIPMER), India, 2023
• Master of Public Health (MPH), JIPMER, India, 2015
• Bachelor of Science in Nursing, JIPMER, India, 2013

• HTAsiaLink Early Career Researcher Programme Award, 2024–2025
• Honorary Best Oral Presentation Award, Priorities 2024 Conference, Bangkok, Thailand, 2024
• Conference attendance scholarship to attend ‘Priorities 2024 Conference’ in Bangkok, Thailand
• International travel support award to attend ‘17th World Congress on Public Health, Rome, Italy in 2023,’ by Science and Engineering Research Board (SERB), Government of India

• Research Fellow, Saw Swee Hock School of Public Health, National University of Singapore, Singapore, 2026–present
• Scientist-D / Project Research Scientist III, Health Technology Assessment Regional Resource Hub, Jawaharlal Institute of Postgraduate Medical Education & Research (JIPMER), India, 2023–2025
• Scientist-C / Research Officer, Health Technology Assessment Regional Resource Hub, JIPMER, India, 2020–2023
• Training Coordinator, Department of Epidemiology, National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru, India, 2016–2017
• Research Officer, Department of Epidemiology, NIMHANS, Bengaluru, India, 2016
• Consultant, Centre for Chronic Disease Control (CCDC), Gurgaon, India, 2016

• Kar SS, Sivanantham P, Ravel V, Mehndiratta A, Tyagi K, Ollendorf DA. Cost-effectiveness of emicizumab prophylaxis for haemophilia A with inhibitors: an adaptive health technology assessment for the Indian setting. BMJ Evid-Based Med. 2024 May 6;bmjebm-2023-112492.
• Sivanantham P, Anandraj J, Ravel V, Veerasetty NK, Sahithya V, Kar SS. Equity Considerations in Health Economic Evaluations: A Systematic Review of WHO South-East Asia Region Countries. WHO South-East Asia Journal of Public Health. 2024 Dec;13(2):69.
• Sivanantham P, S MK, Essakky S, Singh M, Ghosh S, Mehndiratta A, et al. Cost-effectiveness of implementing risk-based cardiovascular disease (CVD) management using updated WHO CVD risk prediction charts in India. PLoS One. 2023;18(8):e0285542.
• Sahithya V, Sivanantham P, Anandraj ,Jeyanthi, Parameswaran ,Sreejith, and Sekhar Kar S. Economic cost of hemodialysis and peritoneal dialysis under public–private partnership in a public tertiary care centre of Puducherry, India. Expert Review of Pharmacoeconomics & Outcomes Research. 2025 Mar 16;25(3):415–21.
• Sivanantham P, Sahoo J, Lakshminarayanan S, Bobby Z, Kar SS. Profile of risk factors for Non-Communicable Diseases (NCDs) in a highly urbanized district of India: Findings from Puducherry district-wide STEPS Survey, 2019–20. PLOS ONE. 2021 Jan 12;16(1):e0245254.
• Sivanantham P, Kar SS, Lakshminarayanan S, Sahoo JP, Bobby Z, Varghese C. Performance of WHO updated cardiovascular disease risk prediction charts in a low-resource setting – Findings from a community-based survey in Puducherry, India. Nutr Metab Cardiovasc Dis. 2022 Sep 1;32(9):2129–36.

View full list of publications here.